EP1833821
Súlfamíð sem endótelín viðtaka mótlyf fyrir meðhöndlunina á hjarta- og æðasjúkdómum.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.11.2005EP published:
30.3.2011EP application number:
05802290.6
EP translation filed:
20.5.2011Grant published:
15.6.2011EPO information:
European Patent Register
Max expiry date:
10.11.2025Expiry date:
10.11.2014
Title:
SULFAMIDES AS ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
Timeline
Today
11.11.2005EP application
30.3.2011EP Publication
20.5.2011Translation submitted
15.6.2011Registration published
10.11.2014Expires
Owner
Name:
Actelion Pharmaceuticals Ltd.Address:
Gewerbestrasse 16, 4123, Allschwil, CH
Inventor
Name:
BOSS, ChristophAddress:
Allschwil, CH
Name:
FISCHLI, WalterAddress:
Allschwil, CH
Name:
WELLER, ThomasAddress:
Binningen, CH
Name:
CLOZEL, MartineAddress:
Binningen, CH
Name:
BOLLI, MartinAddress:
Allschwil, CH
Agent
Name:
Reynaldsson Patent ConsultingAddress:
Pósthólf 48, 212, Garðabæ,
Priority
Number:
PCT/EP2004/012774Date:
11.11.2004Country:
WO
Classification
Categories:
C07D 403/12, A61P 9/00, A61K 31/506
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 21.10.2011
Expires: 10.11.2012
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 19.10.2012
Expires: 10.11.2013
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 21.10.2013
Expires: 10.11.2014
Payer: G. H. Sigurgeirsson